Literature DB >> 16205341

The superior mesenteric artery syndrome in patients with spinal deformity.

Haluk Altiok1, John P Lubicky, Christopher J DeWald, Jean E Herman.   

Abstract

STUDY
DESIGN: A retrospective review.
OBJECTIVE: To determine the incidence of the superior mesenteric artery syndrome (SMAS) after surgical correction for scoliosis and if it is influenced by newer derotation/translation surgical systems. SUMMARY OF BACKGROUND DATA: The SMAS is a known complication after surgery.
METHOD: Of 2939 charts reviewed, 17 patients between 1960 and 2002 matched inclusion criteria.
RESULTS: Our incidence of the SMAS was 0.5%. Onset of symptoms was 7.2 days. Several scoliosis diagnoses were included in the study group. Instrumentation that was used included: nondistraction systems (n = 14), Harrington rod with body cast (n = 1), Luque rod with sublaminar wires (n = 1), and casted in situ posterior spinal fusion (n = 1). Before surgery, 10 of 17 patients weighed less than the 50th percentile. Mean preoperative BMI was 18.6 kg/cm/cm. Postoperative height gain averaged 3.175 cm, and weight loss at onset of symptoms averaged 4.5 kg. There were 14 patients who required nasogastric suction for an average duration of 10.2 days, 11 required hyperalimentation, and 5 concurrently received hyperalimentation with enteric feeding. The SMAS recurred in 2 patients.
CONCLUSIONS: Postoperative weight loss appears to be more important for the development of the SMAS than asthenic body type. Newer derotation/translation corrective techniques have not eliminated the SMAS. Gastrointestinal imaging is indicated when nausea and vomiting occur 6-12 days after surgery, associated with early satiety and normal bowel sounds. Decompression and nutritional support remain the mainstays of treatment.

Entities:  

Mesh:

Year:  2005        PMID: 16205341     DOI: 10.1097/01.brs.0000181059.83265.b2

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  14 in total

1.  Duodenojejunal junction web masquerading as Wilkie's syndrome: report of a case.

Authors:  Somprakas Basu; Vivek Srivastava; Pramod Kumar Singh; Arvind Srivastava; Vijay Kumar Shukla
Journal:  Surg Today       Date:  2011-03-02       Impact factor: 2.549

2.  Superior mesenteric artery syndrome: where do we stand today?

Authors:  Tae Hee Lee; Joon Seong Lee; Yunju Jo; Kyung Sik Park; Jae Hee Cheon; Yong Sung Kim; Jae Young Jang; Young Woo Kang
Journal:  J Gastrointest Surg       Date:  2012-10-18       Impact factor: 3.452

3.  Unusual delayed presentation of superior mesenteric artery syndrome following scoliosis correction surgery-a case report and review of literature.

Authors:  Karthikeyan Maharajan; Joseph Shanthakumar Thambiah
Journal:  J Spine Surg       Date:  2017-06

4.  Superior mesenteric artery syndrome.

Authors:  Rajeev Jain
Journal:  Curr Treat Options Gastroenterol       Date:  2007-02

5.  Late presentation of superior mesenteric artery syndrome following scoliosis surgery: a case report.

Authors:  Athanasios I Tsirikos; Raymond E Anakwe; Alexander D L Baker
Journal:  J Med Case Rep       Date:  2008-01-19

6.  Superior mesenteric artery syndrome: an infrequent complication of scoliosis surgery.

Authors:  Metin Keskin; Turgut Akgül; Adem Bayraktar; Fatih Dikici; Emre Balık
Journal:  Case Rep Surg       Date:  2014-10-22

7.  Late-onset superior mesenteric artery syndrome four years following scoliosis surgery - a case report.

Authors:  Nariman Abol Oyoun; Muayad Kadhim; John P Dormans
Journal:  SICOT J       Date:  2015-06-15

8.  Superior mesenteric artery syndrome.

Authors:  Giedrius Bernotavičius; Kęstutis Saniukas; Irena Karmonaitė; Rimantas Zagorskis
Journal:  Acta Med Litu       Date:  2016

9.  Superior Mesenteric Artery Syndrome-Believe in it! Report of a Case.

Authors:  Sante Capitano; Gianfranco Donatelli; Gianfranco Boccoli
Journal:  Case Rep Surg       Date:  2012-08-05

10.  Optimal duration of medical treatment in superior mesenteric artery syndrome in children.

Authors:  Myung Seok Shin; Jae Young Kim
Journal:  J Korean Med Sci       Date:  2013-07-31       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.